Nemaura Medical Inc. (NMRD) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Nemaura Medical Inc. (NMRD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.00

null (null%)

At close: Jan 14, 2025, 8:00 PM

undefined% (undefined)

Bid	0.11
Market Cap	4.04K
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.39
PE Ratio (ttm)	0
Forward PE	n/a
Analyst	Buy

Ask	0.13
Volume	1,425
Avg. Volume (20D)	5,745
Open	0.00
Previous Close	undefined
Day's Range	0.00 - 0.00
52-Week Range	0.00 - 0.13
Beta	undefined

About NMRD

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Feb 5, 2018

Employees 36

Stock Exchange NASDAQ

Ticker Symbol NMRD

Website https://nemauramedical.com

Analyst Forecast

According to 1 analyst ratings, the average rating for NMRD stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

News

1 year ago · zacks.com

Nemaura (NMRD) to Expand in UK With Metabolic Health Program

The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.

1 year ago · pennystocks.com

Best Penny Stocks To Buy Now? 10 Under $1 To Watch

Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.

1 year ago · zacks.com

Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?

Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 year ago · businesswire.com

Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

LOUGHBOROUGH, England--( BUSINESS WIRE )--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable...

1 year ago · businesswire.com

Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants

2 years ago · zacks.com

Nemaura Medical, Inc. (NMRD) Reports Q1 Loss, Lags Revenue Estimates

Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of -6.25% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

2 years ago · seekingalpha.com

Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market

The Continuous Glucose Monitoring Market is expanding to consumer-centered CGM wellness devices, targeting Type-2 diabetics, prediabetics, and healthy consumers.

3 years ago · pulse2.com

NMRD Stock: Why It Increased Today

The stock price of Nemaura Medical, Inc. (NASDAQ: NMRD) increased by over 4% today. This is why it happened.

3 years ago · seekingalpha.com

Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move

Nemaura is an intriguing company developing a wearable patch for monitoring of glucose & blood sugar levels by Type-2 and pre-diabetes patients.

3 years ago · benzinga.com

Nemaura Medical Makes Progress with Advanced Noninvasive Sensors for Diabetes Management and Metabolic Health

For millions of diabetic patients worldwide, the reality of constantly having needles pricked into the body for glucose monitoring can be a never-ending nightmare. With over 460 million people current...

3 years ago · pulse2.com

Nemaura Medical (NMRD) Stock: 140.69% Increase This Past Month Explanation

The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased by 140.69% this past month. This is why it happened.

3 years ago · pennystocks.com

Former Penny Stocks To Watch Making Their Mark In 2021

These penny stocks hit it out of the park in 2021 & continue to climb in May. The post Former Penny Stocks To Watch Making Their Mark In 2021 appeared first on Penny Stocks to Buy, Picks, News and Inf...

3 years ago · benzinga.com

Nemaura Medical Stages Epic Reversal

Shares of Nemaura Medical Inc. (NASDAQ:NMRD) may be about to drop even more than they have so far today. On Wednesday, the bulls were firmly in control.

3 years ago · pulse2.com

NMRD Stock: 12.57% Increase (From $11.06 To $12.58) Pre-Market Explanation

The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased 12.57% (from $11.06 to $12.58) pre-market. This is why it happened.

3 years ago · benzinga.com

Why Nemaura Medical's Stock Surged 135% Today

Nemaura Medical Inc. (NASDAQ: NMRD) shares are trading higher after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Et...

3 years ago · pulse2.com

NMRD Stock: From $4.70 To $8.20 (74.46% Increase) Intraday Explanation

The stock price of Nemaura Medical Inc (NASDAQ: NMRD) increased from $4.70 to a day high of $8.20 during intraday trading. This is why it happened.